VerbatimParliament, as it happens

Coronavirus: Vaccination

Asked by Esther McVeyConservativeDepartment of Health and Social CareTabled Answered 29 April 2026UIN 129083

The question

To ask the Secretary of State for Health and Social Care, if he will publish the most recent Medicines and Healthcare products Regulatory Agency (MHRA) pharmacovigilance assessment or signal evaluation report that specifically addresses potential cancer/neoplasm signals in relation to COVID-19 vaccines.

Answered by Dr Zubir Ahmed

The Medicines and Healthcare products Regulatory Agency (MHRA) has not performed a signal assessment of ‘potential cancer/neoplasm’ in relation to COVID-19 vaccines authorised for use in the United Kingdom as there have not been any signals of this nature. The MHRA keeps emerging safety information under close review and will take appropriate actions should any new safety concerns be confirmed, communicating to healthcare professionals and the public as appropriate.

Verbatim has judged this answer against the question that was actually asked — answered, partly answered, or evaded. Sign in to see the verdict →

Open this question in Verbatim →

Every written question, searchable

155,000 questions tabled since the election, with the answer each department gave — and the ones still unanswered, with the clock running. Free to search.

Search written questions →Read on Verbatim